Skip to main content

Table 1 (abstract P59). Patient Characteristics

From: Proceedings of the 2018 Childhood Arthritis and Rheumatology Research Alliance (CARRA) Scientific Meeting

 

PICU PSV Cohort (n=18)

Median age, years (IQR)

9.5 (5.9-13.7)

Male/Female, n (%)

7 (38.9)/11 (61.1)

Diagnosis, n (%)

 

 Refractory Kawasaki disease

6 (33.3)

 Takayasu’s arteritis

5 (27.8)

 ANCA-associated vasculitis

4 (22.2)

 Henoch-Schonlein purpura

2 (11.1)

 Primary CNS Vasculitis

1 (5.6)

 Others

0 (0)

Diagnosis during hospital admission, n (%)

15 (83.3)

Treatment during hospitalization

 

 Glucocorticoids

15 (83.3)

 IVIg

7 (38.9)

 Aspirin

5 (27.8)

 Cyclophosphamide

4 (22.2)

 Disease modifying anti-rheumatic drugs

2 (11.2)

 Biologics

1 (5.6)

Median hospital length of stay, days (IQR)

8.5 (4.0-18.8)